Benepass Secures $40M in Series B Funding for Benefits Capital Management Platform

In a market where benefits have quietly become one of the largest capital line items on a company’s balance sheet, Benepass decided to stop pretending this was an HR problem. It treated benefits like money, because that is exactly what they are. Real dollars. Real rules. Real consequences when the system breaks. That framing alone explains why this company feels different the moment you look under the hood.

Founded in 2019 and built across New York, Oakland, and Salt Lake City, Benepass was shaped by people who know infrastructure, not platitudes. Jaclyn Chen came out of Goldman Sachs and TPG Capital with a sharp eye for capital flow. Mark Fischer brought systems thinking forged at Google and X, where precision is non-negotiable. Kabir Soorya arrived from In Q Tel and Sidewalk Labs with deep experience building platforms that do not get second chances. That mix shows up in the product philosophy, not the pitch deck.

Instead of stitching together vendors and hoping employees figure it out, Benepass built a proprietary financial ledger and real-time authorization engine that treats benefits like a live system. Pre-tax accounts, post-tax lifestyle spending, physical and virtual Visa cards, instant eligibility checks, immediate feedback at the point of purchase. No batch processing theater. No mystery balances. Just clean execution where money moves when and where it is supposed to.

That clarity is why more than 250 employers now trust the platform across 80 plus countries, reaching over 400,000 employees. It is why over 4.5 million transactions have flowed through the system and more than $500 million in benefit dollars have actually been used, not forgotten. Engagement hovering near 98 percent is not a metric you get by accident in benefits. It is what happens when friction gets engineered out instead of explained away.

The market noticed. In January 2026, Benepass closed a $40 million Series B led by Centana Growth Partners, with FoW Partners joining and continued conviction from Portage Ventures and Threshold Ventures. Matthew Alfieri of Centana did not talk about vibes. He talked about customer praise, flexibility, and execution. Stephanie Choo’s presence on the board reinforces that this is institutional capital backing infrastructure, not experimentation.

The next chapter leans directly into the hardest cost problem employers are facing. Specialty reimbursement accounts focused on high-cost medications like GLP 1s, built with the same rule-driven discipline as the core platform. Not cost shifting. Not benefit inflation. Precision control over how health dollars are deployed, measured, and adjusted.